CD8A and type 1 diabetes mellitus: Therefore, we conducted the first longitudinal study to specifically evaluate the inherent variation of peripheral immune cell subsets (autoreactive CD8+ T cells, broad T‐cell memory, NK and monocyte cell subsets) in prediabetic individuals as part of the Type 1 Diabetes Longitudinal Biomarker Trial (T1DBIT).